Skip To Main Content
Barr Fritcher on Muck Rack

Barr Fritcher

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Barr

Contact Barr, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Cholangiocarcinoma - evolving concepts and therapeutic strategies

|
By Barr Fritcher, Darwish Murad, Sumera Rizvi, von Seth
| Nature Verified
Abstract Cholangiocarcinoma is a disease entity comprising diverse epithelial tumours with features of cholangiocyte differentiation: cholangiocarcinomas are categorized according to anatomical location as intrahepatic (iCCA), perihilar (pCCA), or distal (dCCA). Each subtype has a distinct epidemiology, biology, prognosis, and strategy for clinical management. The incidence of cholangiocarcinoma, particularly iCCA, has increased globally over the past few decades.
Open in Who Shared Issue with article?

Cholangiocarcinoma - evolving concepts and therapeutic strategies

|
By Darwish Murad, Sumera Rizvi, shahid khan, Barr Fritcher
| Nature Verified
1.Rizvi, S. & Gores, G. J. Pathogenesis, diagnosis, and management of cholangiocarcinoma. Gastroenterology 145, 1215–1229 (2013).2.Saha, S. K., Zhu, A. X., Fuchs, C. S. & Brooks, G. A. Forty-year trends in cholangiocarcinoma incidence in the US: intrahepatic disease on the rise. Oncologist 21, 594–599 (2016).3.Khan, S. A. et al. Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J. Hepatol. 37, 806–813 (2002).4.Taylor-Robinson, S. D. et al.
Open in Who Shared Issue with article?
See all 2 articles